Sweet sorghum:agronomic practice for food, animal feed and fuel production in Sub-Saharan Africa

Sweet sorghum is a cereal that belongs to the species Sorghum bicolor (L) Moench. Although the crop is reportedly native to Africa, it is grown worldwide largely because it thrives well under wide rainfall regimes, varied day lengths, soil conditions and can tolerate varying degrees of biotic and abiotic factors and stresses. This chapter reviews and discusses the physiology and adaptation of sweet sorghum crops to varied environmental and climatic conditions across Sub-Saharan Africa. Several research works have indicated that numerous improved cultivar types of sweet sorghum are grown across Africa. Virtually all sweet sorghum cultivars are primarily grown to produce grain, sugary stalk juice and forage or fodder. The grains are considered the 3rd most important source of staple food to people living in the Sub-Saharan Africa region. Furthermore, the grains may also be malted to produce beverages or utilized as adjunct in beer brewing. However, the sugary stalk juice is most commonly used for sorghum molasses or syrup production. Sorghum molasses or syrup is a suitable alternative to refined cane sugars for beverage consumption; particularly for diabetic patients. Thus, the nutritional value, health benefits and future prospects of sorghum grain consumption to address certain human health challenges are discussed in this chapter. Alternatively, the sugary stalk juice from sorghum may be bio-converted to bioethanol (a fuel alcohol). Sweet sorghum crop residues (i.e., leftovers and after the grains are harvested and stalk juice extracted) can serve as animal feed or utilized as lignocellulosic biomass for second generation bioethanol production. This chapter reviews and discusses literature that demonstrates sweet sorghum is a cereal crop with high tolerance to diverse environmental and climatic conditions. In addition, the crop produces nutritious grains and sugary stalk juice that are of important health and economic benefits for domestic and industrial applications throughout in Africa

Improved production of ethanol using bagasse from different sorghum cultivars

For improved production of ethanol from whole sorghum residues, physico-chemical compositions and fermentation characteristics of the substrates are important factors to consider. In the present study, Nigerian sorghum cultivars SSV2, KSV8 and KSV3 were grown under rain-fed conditions without chemical fertilization in Kano state, Nigeria. On harvest, the whole sorghum residues (bagasse) comprising crushed stalks, leaves, panicles and peduncles were collected for further processing. Bagasse samples, which had different macromolecular composition and carbohydrate pasting properties, were pre-treated with dilute sulphuric acid at 75 °C followed by enzymatic hydrolysis and sequential detoxification by Ca(OH)2 over-liming and charcoal filtration. Hydrolysate samples were subsequently fermented with the yeasts, Saccharomyces cerevisiae and Pachysolen tannophilus. Sugar consumption, carbon dioxide evolution and ethanol production were shown to vary depending on the sorghum cultivar type. While KSV3 yielded most favourable biomass of 37 t ha−1 (dry basis), bagasse from cultivar SSV2 yielded the most favourable level of sugars (69 g/100 g) after enzymatic hydrolysis, and also consistently exhibited improved fermentation performance. Detoxification of pre-treated sorghum bagasse to remove potential yeast inhibitors resulted in improvement in ethanol yield, with 23 g L−1 ethanol (representing 72% of theoretical yield) being achieved from SSV2 bagasse following fermentation with P. tannophilus without exogenous nutrient supplementation. Our findings reveal that the choice of sorghum cultivar is important when converting bagasse to ethanol, and further that pretreatment with dilute acid at moderate temperature followed by detoxification improves fermentation kinetics and ethanol yield

Fermentation of stalk juices from different Nigerian sorghum cultivars to ethanol

For improved production of ethanol from sorghum stalk juice fermentation, cultivation location and cultivar type are important factors to consider. In the present study, SSV2 and KSV8 sorghum cultivars were cultivated in Kano and Kaduna states in Nigeria that exhibit notably different rain precipitation and diurnal temperatures. The crude stalk juices (without pre-treatment or nutrient supplementation) were extracted from these sorghum samples and fermented with a distiller’s strain of the yeast, Saccharomyces cerevisiae. Sugar consumption and alcohol production were determined by HPLC and GC-MS, respectively. When it was grown in the Kaduna site, SSV2 was identified as the highest yielding sorghum cultivar from which we extracted the maximum levels of extractable sugars (161.50 g l-1 ) that yielded favourable ethanol levels of 80.56 g l-1 following fermentation. Our findings show that relatively colder and wetter cultivation sites are preferred for sorghum stalk juice destined for bioethanol production.<br/

Utilization of whole sorghum crop residues for bioethanol production

Sorghum is the fifth most important cereal worldwide and is a major source of agricultural residues in tropical regions. Bioconversion of whole sorghum crop residues comprising stalks, leaves, peduncles and panicles to ethanol has great potential for improving ethanol yield per sorghum crop cultivated, and for sustainable biofuel production. Effective pretreatment of sorghum lignocellulosic biomass is central to the efficiency of subsequent fermentation to ethanol. Previous studies have focused on bioconversion of sorghum stalks and/or leaves only to bioethanol, but the current study is the first report dealing with whole crop residues. We specifically focused on the impact of Nigerian sorghum cultivation location and cultivar type on the potential ethanol yield from whole sorghum crop residues. Efficient bioconversion of whole sorghum residues to ethanol provides a sustainable route for utilisation of crop residues thereby providing a non-food feedstock for industrial scale bioethanol production

Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies

Nuclear factor E2-related factor 2 (NRF2), a transcription factor, is a master regulator of an array of genes related to oxidative and electrophilic stress that promote and maintain redox homeostasis. NRF2 function is well studied in in vitro, animal and general physiology models. However, emerging data has uncovered novel functionality of this transcription factor in human diseases such as cancer, autism, anxiety disorders and diabetes. A key finding in these emerging roles has been its constitutive upregulation in multiple cancers promoting pro-survival phenotypes. The survivability pathways in these studies were mostly explained by classical NRF2 activation involving KEAP-1 relief and transcriptional induction of reactive oxygen species (ROS) neutralizing and cytoprotective drug-metabolizing enzymes (phase I, II, III and 0). Further, NRF2 status and activation is associated with lowered cancer therapeutic efficacy and the eventual emergence of therapeutic resistance. Interestingly, we and others have provided further evidence of direct NRF2 regulation of anticancer drug targets like receptor tyrosine kinases and DNA damage and repair proteins and kinases with implications for therapy outcome. This novel finding demonstrates a renewed role of NRF2 as a key modulatory factor informing anticancer therapeutic outcomes, which extends beyond its described classical role as a ROS regulator. This review will provide a knowledge base for these emerging roles of NRF2 in anticancer therapies involving feedback and feed forward models and will consolidate and present such findings in a systematic manner. This places NRF2 as a key determinant of action, effectiveness and resistance to anticancer therapy

Characterisation of surfactant-expressing bacteria and their potential bioremediation properties from hydrocarbon-contaminated and uncontaminated soils

We are investigating characteristics associated with oil degradation amongst bacteria isolated from clean and hydrocarbon contaminated soils from Nigeria and the UK.Our focus has been to identify bacteria expressing surfactants following isolation on Pseudomonas selective (PSA-CFC) and non-selective nutrient media and investigate the nature of surfactants, heavy metal resistance and hydrocarbon-degrading enzymes expressed by the bacteria. Of five sites sampled, a total of 1460 colonies were tested using the drop collapse assay, and 110 were found to express surfactants reducing liquid surface tensions as assessed by quantitative tensiometry to between 24.7 and 26.7 mN.m-1 (Tukey-Kramer HSD, α=0.05). We undertook a range of growth and behaviour-based assays on 60 selected strain which, when investigated by Hierarchical cluster analysis (HCA) demonstrated that this collection showed considerable phenotypic diversity. Eight out of the 60 strains could grow at a high temperature (50 °C), 35 of the 60 strains utilized diesel as a sole carbon source, and most of the strains could tolerate high concentrations (up to 20 mM) of heavy metals. Identification by 16S rDNA sequencing revealed that some of the strains belong to Pseudomonas, Bacillus, and Stenotrophomonas genera. We found using bioinformatics analysis of eight-selected draft genome sequences (AntiSMASH and RAST) NRPS-like (probable surfactants), cytochrome P450, catechol-1,2/2,3-dioxygenase, lipase, and heavy metal resistance gene sequences. We intend to use the information provided in this research to select strains for potential applications in in-situor ex-situ bioremediation of hydrocarbon-contaminated soils

Predicting the minimum liquid surface tension activity of pseudomonads expressing biosurfactants

Bacteria produce a variety of biosurfactants capable of significantly reducing liquid (aqueous) surface tension (γ) with a range of biological roles and biotechnological uses. In order to determine the lowest achievable surface tension (γMin), we tested a diverse collection of Pseudomonas-like isolates from contaminated soil and activated sludge, and identified those expressing biosurfactants by drop-collapse assay. Liquid surface tension reducing ability was quantitatively determined by tensiometry, with 57 isolates found to significantly lower culture supernatant surface tensions to 24.5 – 49.1 mN m−1. Differences in biosurfactant behaviour determined by foaming, emulsion and oil-displacement assays, was also observed amongst isolates producing surface tensions of 25 – 27 mN m−1, suggesting that a range of structurally-diverse biosurfactants were being expressed. Individual distribution identification (IDI) analysis was used to identify the theoretical probability distribution that best fitted the surface tension data, which predicted a γMin of 24.24 mN m−1. This was in agreement with predictions based on earlier work of published mixed–bacterial spp. data, suggesting a fundamental limit to the ability of bacterial biosurfactants to reduce surface tensions in aqueous systems. This implies a biological restriction on the synthesis and export of these agents or a physical-chemical restriction on their functioning once produced

Cytochrome P450 CYP1B1 interacts with 8-<i>methoxypsoralen</i> (8-MOP) and influences psoralen-Ultraviolet A (PUVA) sensitivity

Background: There are unpredictable inter-individual differences in sensitivity to psoralen-UVA (PUVA) photochemotherapy, used to treat skin diseases including psoriasis. Psoralens are metabolised by cytochrome P450 enzymes (P450), and we hypothesised that variability in cutaneous P450 expression may influence PUVA sensitivity. We previously showed that P450 CYP1B1 was abundantly expressed in human skin and regulated by PUVA, and described marked inter-individual differences in cutaneous CYP1B1 expression.Objectives: We investigated whether CYP1B1 made a significant contribution to 8-methoxypsoralen (8-MOP) metabolism, and whether individuality in CYP1B1 activity influenced PUVA sensitivity.Methods: We used E. coli membranes co-expressing various P450s and cytochrome P450 reductase (CPR) to study 8-MOP metabolism and cytotoxicity assays in CYP1B1-expressing mammalian cells to assess PUVA sensitivity.Results: We showed that P450s CYP1A1, CYP1A2, CYP1B1, CYP2A6 and CYP2E1 influence 8-MOP metabolism. As CYP1B1 is the most abundant P450 in human skin, we further demonstrated that: (i) CYP1B1 interacts with 8-MOP (ii) metabolism of the CYP1B1 substrates 7-ethoxyresorufin and 17-b-estradiol showed concentration-dependent inhibition by 8-MOP and (iii) inhibition of 7-ethoxyresorufin metabolism by 8-MOP was influenced by CYP1B1 genotype. The influence of CYP1B1 on PUVA cytotoxicity was further investigated in a Chinese hamster ovary cell line, stably expressing CYP1B1 and CPR, which was more sensitive to PUVA than control cells, suggesting that CYP1B1 metabolises 8-MOP to a more phototoxicmetabolite(s).Conclusion: Our data therefore suggest that CYP1B1 significantly contributes to cutaneous 8-MOP metabolism, and that individuality in CYP1B1 expression may influence PUVA sensitivity

Understanding tissue morphology: model repurposing using the CoSMoS process

We present CoSMoS as a way of structuring thinking on how to reuse parts of an existing model and simulation in a new model and its implementation. CoSMoS provides a lens through which to consider, post-implementation, the assumptions made during the design and implementation of a software simulation of physical interactions in the formation of vascular structures from endothelial cells. We show how the abstract physical model and its software implementation can be adapted for a different problem: the growth of cancer cells under varying environmental perturbations. We identify the changes that must be made to adapt the model to its new context, along with the gaps in our knowledge of the domain that must be filled by wet-lab experimentation when recalibrating the model. Through parameter exploration, we identify the parameters that are critical to the dynamic physical structure of the modelled tissue, and we calibrate these parameters using a series of in vitro experiments. Drawing inspiration from the CoSMoS project structure, we maintain confidence in the repurposed model, and achieve a satisfactory degree of model reuse within our in silico experimental system